ARIA is an individual member–based alliance, with a diverse array of members who seek to fulfil ARIA’s . Membership is free and time contributed to general member activities is voluntary.
Become a member
Individuals who have relevant experience can self-nominate using pre-specified criteria found in the expression of interest (EOI) form to join ARIA. The EOIs are assessed by the steering committee on a monthly basis. Please contact the ARIA Secretariat if you have any questions about becoming a member: SCHN-NCIRSGlobal@health.nsw.gov.au
Katarzyna Bolsewicz has been involved in co-designing and implementing WHO Tailoring Immunisation Programmes (TIP) across three local health districts (LHDs) in NSW: Central Coast, Hunter New England and Mid-North Coast for the last 2 years. TIP is a strategy developed by WHO (and implemented in many European countries as well as successfully piloted in Maitland, NSW) that uses social sciences and qualitative approaches to understand the demand and supply barriers and enablers to childhood immunisation in areas of low coverage. Findings are then used by local immunisation stakeholders to design localised, appropriate strategies to get more children up to date on their immunisations. Katarzyna has been working closely with immunisation stakeholders in each LHD, including caregivers, Aboriginal and Torres Strait Islander communities, public health units, public health networks, GP practices, child and family health nurses. She is also a research fellow in social science with NCIRS, where she has been working on exploring and addressing communication barriers and enablers related to influenza vaccination experienced by Aboriginal and Torres Strait Islander communities and health providers working with these communities.
Professor Bines is the Victor and Loti Smorgon Professor of Paediatrics at the University of Melbourne and Royal Children’s Hospital. She leads the Enteric Disease Group at Murdoch Children’s Research Institute working to develop an affordable novel rotavirus vaccine, RV3-BB vaccine, aimed at preventing rotavirus disease from birth in infants worldwide. She is Director of the WHO Collaborative Centre for Child Health and the WHO Rotavirus Reference Laboratory for the Western Pacific region that serves to inform and support surveillance activities to understand the global burden of rotavirus gastroenteritis and inform and support countries in decision making for vaccines. Professor Bines leads the Australian Rotavirus Surveillance Network that monitors the impact of rotavirus vaccine introduction in Australia including assessing evidence for potential vaccine escape strains. Professor Bines has served as a consultant to WHO in the areas of vaccine safety, vaccines in enteric disease and the role of vaccines in antimicrobial resistance. She developed the Brighton Collaboration Clinical Case definition for intussusception and the WHO generic protocol for the assessment of post-licensure safety of rotavirus vaccines. She is a member of the ROTA Council working to accelerate the introduction of rotavirus vaccines.
Dr Geoff Clark is a global public health and international development specialist with more than 25 years' experience working for both multilateral, bilateral and national organisations in senior clinical, management, policy and advisory roles in several countries in the Asia Pacific region. He holds post-graduate qualifications in Infectious Diseases Intelligence, Public Health, Health Management and Law. He has also held leadership roles in setting the health service delivery agenda regionally, including developing policy processes to progress the implementation of health security, health system strengthening and health service delivery goals. His current role is as Senior Health Security Adviser to the Vanuatu Ministry of Health.
Jane is a public health researcher focusing on immunisation and maternal and child health. She is an NHMRC Early Career Research Fellow, and her Fellowship project focuses on understanding parent and health practitioner attitudes towards immunisation and improving uptake in hard-to-reach groups/communities. She is also currently leading a large linked data project examining maternal and infant outcomes following influenza and pertussis during pregnancy and have designed (about to evaluate) a maternal influenza decision aid that will be housed on the MumBubVax website.
Jane is a current and founding member of the Collaboration on Social Science and Immunisation (COSSI) network.
She has completed many projects with parents and health practitioners to understand behavioural and access factors impacting vaccine uptake and has presented the results of this research locally and internationally. Jane has recently started a project with a group of colleagues looking at HPV vaccine uptake in Samoa, Vanuatu and Fiji.
Gulam is an established clinical academic with 131 peer-reviewed publications, 10 national/international awards and over $7M in research grants to date. His research focuses on childhood development, disability, infectious diseases/vaccine preventable diseases and healthcare in high-income countries and low- and middle-income countries (LMICs). Gulam completed his PhD at the University of Sydney (2013), NHMRC Early Career Fellowship (2013-2016) at the Sydney Medical School and Paediatrics and Public Health Medicine Physician Training (2012-2016). Currently, he is Director, Public Health, Director, Medical Research for Central Queensland Hospital and Health Service, Professor of Public Health at Central Queensland University and Adjunct Associate Professor at Sydney Medical School.
Gulam's research is supported by Queensland Health (Queensland Advancing Clinical Research Fellowship 2019-2023) and Australian Cerebral Palsy Alliance Research Foundation. He led a global research program on cerebral palsy (CP) and vaccine preventable childhood disabilities in LMICs using a network of CP registers in Bangladesh, Sri Lanka, Nepal, Indonesia, Vietnam, Zimbabwe, Ghana and Suriname.
Dorothy is a senior research fellow at the Kirby Institute, UNSW, and an honorary research fellow with the Centre for Women’s Infectious Disease at The Royal Women’s Hospital in Melbourne. She holds a Master of Public Health and a PhD in epidemiology. Dorothy's research focuses on development and implementation of novel public health surveillance systems, and the evaluation of vaccination and screening strategies for the prevention of HPV and related diseases.
Since 2014, she has led the development and implementation of a Commonwealth Department of Health funded National HPV Monitoring Program that is evaluating the long-term impact of HPV vaccination on HPV infections. This program has provided the basis for well-cited publications on the impact of Australia’s vaccination program. The program methodology underpinned the design of a world-first project to evaluate the impact of one- and two-dose
HPV vaccine schedules in South Africa funded by NHMRC and the Gates Foundation. Currently, she also coordinates the implementation of serological surveys to track the spread of SARS-CoV-2 infection in Australia. The framework developed will provide a central mechanism for monitoring immunity to the virus as vaccine rolls out in Australia.
Andrew is a clinical epidemiologist with over 20 years’ experience in international public health, sexually transmitted and infectious disease research. Andrew has held a joint appointment with the Papua New Guinea Institute of Medical Research (PNGIMR) and the Kirby Institute for Infection and Immunity in Society, Faculty of Medicine, UNSW Sydney, since 2010. In the last 20 years he has designed and led multi-disciplinary research teams in Australia, Kenya, Myanmar, Papua New Guinea, Solomon Islands, Tanzania, United Kingdom and Vanuatu. In 2007, he established an international collaborative research group at the PNGIMR, where he was head of the Sexual and Reproductive Health Unit and Deputy Director from 2010 to 2015. His research in the last decade has focused on evaluating innovative solutions to improve women’s reproductive health in high-burden, low-resource settings.
Andrew is lead investigator of an NHMRC Centre for Research Excellence in Cervical Cancer Control grant (C4 CRE; 2017-22) and an NHMRC Project Grant to evaluate the impact of 2-dose and 1-dose HPV vaccination schedules on community level HPV prevalence among adolescent girls in South Africa (2019-24); and leads an NHMRC-funded field trial of point-of-care HPV testing and treatment for cervical screening in PNG (2015-20). He is a member of the PNG National Technical Advisory Committee on HPV Vaccination (2016-present) and the PNG National Technical Working Group on Comprehensive Cervical Cancer Control (2017-present). He has been a board member of the PNG National Cancer Foundation since its inception in 2013. He jointly organised a regional meeting on cervical cancer in the Pacific, held in Fiji and attended by representatives from seven countries, WHO, UNFPA, and UNICEF that led to a joint Call to Action on Cervical Cancer Elimination (December 2019). He was subsequently asked to take a lead role in progressing the elimination agenda in PNG and Vanuatu from 2020.
Jennifer is a clinician researcher, working as a general paediatrician and paediatric infectious diseases specialist at the Royal Darwin Hospital, and co-leading the Menzies Timor-Leste projects with Dr Josh Francis. Her work with Menzies is focused around Indigenous and global child health, particularly in areas of antimicrobial resistance, infectious diseases, rheumatic heart disease and health system strengthening. Immunisation and vaccine preventable diseases are therefore a core part of her work, both in the Northern Territory in Australia and in Timor-Leste. Menzies, through the STRONG-TL project, supports VPD epidemiology, surveillance and outbreak management. Menzies is a collaborating partner in the ARIA work to be conducted in Timor-Leste.
Jennifer is also a senior lecturer with Flinders University and teaches medical students about immunisation and vaccine preventable disease. Previous overseas experience includes capacity building and improving quality of care in resource-limited settings with work in Laos, Malawi and India.